摘要:
A modified human complement C3 protein (C3) is disclosed comprising a substitution of a portion of a human C3 protein, with a corresponding portion of a Cobra Venom Factor protein (CVF) which results in a human C3 protein with CVF functions, but with substantially reduced immunogenicity. Advantageously, the C3 protein can be manipulated to contain at least one of the following CVF functions: increased stability of the C3 convertase and increased resistance to the actions of factors H and/or I. A large number of hybrid C3 proteins containing substitutions in the C-terminal portion of the alpha chain of C3 are presented and tested for the above functions. Methods of treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation are presented as well as methods of increasing the effectiveness of gene therapeutics and other therapeutics.
摘要:
Structural component made of powder metallurgical materials, particularly temperature resistant alloys, nickel base alloys, are produced by injection molding or pressing. The sintering is divided into individual work steps for producing dense and smooth structural components which are true to shape.
摘要:
In the method according to the invention, the inlet pressure and the inlet cross section of the fuel pre-stored in the pump work chamber is constant, and it is solely the opening duration of an inlet valve which is electrically regulated. In addition, a shift in the instant of supply onset controlled in accordance with operating characteristics is attained by means of a variation in the return-flow fuel quantity. A shift in the instant of supply onset, which is undesired when there is a change in the quantity of fuel to be injected, is prevented by means of a simultaneously-effected correction of the return-flow fuel quantity. A fuel injection apparatus suitable for performing the method has, as the inlet valve, a magnetic valve which determines the quantity of fuel pre-stored in the pump work chamber. The rotary position of the pump piston is variable in order to shift or correct the instant of supply onset by means of an adjacent device actuated by an electromechanical adjustment element. An electric control device emitting the metering pulse and a control pulse is connected with a set-point transducer and an adjustment-path transducer of the adjustment device. The apparatus can be equipped with either a pump/nozzle or a normal piston injection pump supplying the injection nozzle via a pressure line, or with a distributor injection pump.
摘要:
A modified human complement C3 protein (C3) is disclosed comprising a substitution of a portion of a human C3 protein, with a corresponding portion of a Cobra Venom Factor protein (CVF) which results in a human C3 protein with CVF functions, but with substantially reduced immunogenicity. Advantageously, the C3 protein can be manipulated to contain at least one of the following CVF functions: increased stability of the C3 convertase and increased resistance to the actions of factors H and/or I. A large number of hybrid C3 proteins containing substitutions in the C-terminal portion of the alpha chain of C3 are presented and tested for the above functions. Methods of treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation are presented as well as methods of increasing the effectiveness of gene therapeutics and other therapeutics.
摘要:
A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a functional moiety to localize the functional moiety in the target area. Preferably the targeting moiety is an antibody and the functional moiety is a radiometal when performing in vivo imaging or therapy. The affinity component may be a novel methotrexate analog. Preferably, the affinity component is thermo-stabilized.
摘要:
Site-specific heterobifunctional crosslinkers of the formula:X--COCH(NH.sub.2)--Y--Zwhere X is a carbonyl reactive group, Y is a variable length spacer, and Z is a thiol reactive group, are useful for the specific labelling of biomolecules or bioaffecting molecules.
摘要:
A fuel injection nozzle for internal combustion engines having a valve needle which enters an intermediate position in a retarded fashion and subsequently reaches its final position quickly. The valve needle is coupled in a positively-engaged manner with a supplementary body which as a result of its mass and/or hydraulically damps the movement of the valve needle over the course of a first stroke portion. At the end of this stroke portion, the supplementary body strikes a shoulder attached to the housing, whereupon the valve needle after the attainment of a notably higher fuel pressure, is separated from the supplementary body and translated quickly into its open position. In special cases, it is also possible for two supplementary bodies to be provided, which are uncoupled one after another from the valve needle and then again recoupled to the valve upon the closure of the valve. With an apparatus of this kind, the injection procedure can be adapted more freely than in the case of the known injection nozzles to a desired course.
摘要:
The invention provides modified human complement C3 proteins, comprising a human C3 protein, wherein amino acid residues in the human C3 protein are substituted with a corresponding portion of a Cobra Venom Factor (CVF) protein, and wherein one or more amino acid residues in the CVF portion of the modified human complement C3 protein are further modified.
摘要:
A modified human complement C3 protein (C3) is disclosed comprising a substitution of a portion of a human C3 protein, with a corresponding portion of a Cobra Venom Factor protein (CVF) which results in a human C3 protein with CVF functions, but with substantially reduced immunogenicity. Advantageously, the C3 protein can be manipulated to contain at least one of the following CVF functions: increased stability of the C3 convertase and increased resistance to the actions of factors H and/or I. A large number of hybrid C3 proteins containing substitutions in the C-terminal portion of the alpha chain of C3 are presented and tested for the above functions. Methods of treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation are presented as well as methods of increasing the effectiveness of gene therapeutics and other therapeutics.